Source:http://linkedlifedata.com/resource/pubmed/id/21200904
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| pubmed:issue |
Pt 1
|
| pubmed:dateCreated |
2011-1-4
|
| pubmed:abstractText |
In the title compound, C(26)H(24)BrN(3)O(2), the isoxazolidine ring adopts an envelope conformation, the ring N atom deviating from the mean plane of the other four atoms by an angle of 0.286°. The orientation of the phenyl ring is +sp and the bromophenyl ring is +sc relative to the attached pyrazole ring; the dihedral angles between the least-squares planes of the pyrazole and the attached phenyl and bromophenyl rings are 21.8?(3) and 41.8?(3)°.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:issn |
1600-5368
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
64
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
o342
|
| pubmed:dateRevised |
2011-11-11
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
3-[3-(4-Bromo-phen-yl)-1-phenyl-1H-pyrazol-4-yl]-5-eth-oxy-2-phenyl-isoxazolidine.
|
| pubmed:publicationType |
Journal Article
|